跳至主要内容
临床试验/NCT04142775
NCT04142775Unknown不适用

Predictors of Intracranial Hemorrhage in Critically Ill Patients With Acute Lung Failure (ARDS) on Extracorporeal Membrane Oxygenation (ECMO)

Charite University, Berlin, Germany1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2019年2月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,000
试验地点
1
主要终点
mortality

研究概览

简要总结

Intracranial hemorrhage is is a rare, but critical incident in patients with acute lung failure undergoing ECMO therapy. Predictors of intracranial hemorrhage are yet to be defined to identify patients at (high) risk. This retrospective analysis investigates the predictive value and validity of parameters and specific risk factors of critically ill ARDS patients treated with ECMO.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ARDS following Berlin definition (mild, moderate, severe)
  • ECMO therapy (veno-venous cannulation)

排除标准

  • ECMO, other than VV
  • ICH at initiation of ECMO
  • no cerebral CT scan at any time

结局指标

主要结局

mortality

时间窗: up to 28 days

mortality after ICH/no ICH in ARDS patients with ECMO

次要结局

  • ICU stay(up to 28 days)
  • ventilator/ECMO-free days(up to 28 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mario Menk

Principal Investigator

Charite University, Berlin, Germany

研究点 (1)

Loading locations...

相似试验